Search

Search Results

• 

  Subcalcaneal bursitis as the initial manifestation of rheumatoid arthritis: ultrasonographic observation of two cases

  T. Suzuki, H. Shirai

  230-234

  28-01-2020

  Published: 28 January 2020

  1298

  PDF: 929
• 

  Rheumatologic rehabilitation: towards recommendations

  S. Maddali Bongi, A. Del Rosso, M. Matucci Cerinic

  197-207

  06-11-2014

  Published: 6 November 2014

  1927

  PDF: 1227

• TNFα blockers and infectious risk in rheumatoid arthritis

  B. Raffeiner, C. Botsios, F. Ometto, L. Bernardi, A. Montante, P. Sfriso, S. Todesco, L. Punzi

  165-173

  Published:

  1526

  PDF: 2049

• Clinical utility of lung ultrasound for the detection of interstitial lung disease in patients with rheumatoid arthritis

  R. Tanten Zabaleta, J. Marín, J.B. Zacariaz Hereter, J. Maritano, M. Fullana, N. Alvarado, E.R. Soriano, J.E. Rosa

  03-10-2024

  Published: 3 October 2024

  667

  PDF: 74
• 

  A clinical overview of bone marrow edema

  M. Manara, M. Varenna

  184-196

  28-07-2014

  Published: 28 July 2014

  10423

  PDF: 5201

• Effects of estrogen peripheral metabolism in rheumatoid arthritis

  S. Capellino, P. Montagna, B. Villaggio, M. Cutolo

  78-82

  Published:

  1285

  PDF: 1832

• Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

  L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

  182-186

  Published:

  960

  PDF: 664

• Septic arthritis: what is the role for the rheumatologist?

  F. Schiavon, M. Favero, V. Carraro, L. Riato

  1-5

  Published:

  1165

  PDF: 1375

• Recombinant adenovirus-mediated gene transfer suppresses experimental arthritis

  E. Quattrocchi, M. Feldmann

  46-54

  Published:

  648

  PDF: 687

• TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

  I. Cavazzana, F. Bobbio-Pallavicini, C. Bazzani, E. Bravi, S. Zingarelli, A. Ceribelli, R. Caporali, R. Cattaneo, F. Franceschini, C. Montecucco

  275-282

  Published:

  964

  PDF: 897
• 

  Thermal alterations in patients with inflammatory diseases: a comparison between psoriatic and rheumatoid arthritis

  A. Capo, J. Di Paolo, E. Celletti, E. Ismail, A. Merla, P. Amerio

  225-231

  20-12-2018

  Published: 20 December 2018

  1324

  PDF: 930

• “THE LEEDS IDEA”: AN HISTORICAL ACCOUNT OF THE SPONDARTHRITIS CONCEPT

  J.M.H. Moll

  13-18

  Published:

  751

  PDF: 716

• IL-1Ra: its role in rheumatoid arthritis

  M. Cutolo

  41-45

  Published:

  1339

  PDF: 2214

• Rheumatoid arthritis and atherosclerosis

  B. Seriolo, A. Sulli, B. Burroni, M. Cutolo

  140-146

  Published:

  1771

  PDF: 2725

• Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis

  G.L. Erre, A. Tocco, R. Faedda, A. Cossu, A. Carcassi

  118-123

  Published:

  991

  PDF: 5796

• Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, C.M. Montecucco

  197-211

  Published:

  1131

  PDF: 867

• Early rheumatoid arthritis

  F. Atzeni, P. Sarzi-Puttini

  100-117

  Published:

  1389

  PDF: 2039
• 

  Psoriasis and family history of psoriasis may not affect disease severity of rheumatoid arthritis

  N. Şen, R. Mercan, G. Geçmez, B. Ediz, O. Volkan, S. Yilmaz-Oner, M.E. Tezcan

  07-02-2022

  Published: 7 February 2022

  5387

  PDF: 581
• 

  Extra-articular rheumatoid arthritis

  E. Marcucci, E. Bartoloni, A. Alunno, M.C. Leone, G. Cafaro, F. Luccioli, V. Valentini, E. Valentini, G.M.C. La Paglia, A.F. Bonifacio, R. Gerli

  212-224

  20-12-2018

  Published: 20 December 2018

  7911

  PDF: 4171

• B Lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis

  L. Quartuccio, M. Fabris, G. Ferraccioli

  143-146

  Published:

  1382

  PDF: 1007

• Case report: rheumatoid arthritis and large granular lymphocytes syndrome

  F. Ingegnoli, M. Arreghini, B. Panni, R. Capra, F. Galbiati, P. Bonara, A. Marchesoni

  357-360

  Published:

  1026

  PDF: 2081

• The subclinical involvement of the lung in rheumatoid arthritis: evaluation by high-resolution computed tomography

  M. Carotti, F. Salaffi, P. Manganelli, L. Salvolini, E. Bichi Secchi, S. De Berardinis

  280-288

  Published:

  1088

  PDF: 1511
• 

  Novel autoantibodies in rheumatoid arthritis

  A.F. Bonifacio, A. Alunno, G.M.C. La Paglia, E. Valentini, M.C. Leone, E. Bartoloni, Roberto Gerli

  1-12

  01-04-2019

  Published: 1 April 2019

  2859

  PDF: 1650

• Kidney involvement in rheumatoid arthritis

  A. Icardi, P. Araghi, M. Ciabattoni, U. Romano, P. Lazzarini, G. Bianchi

  76-85

  Published:

  5284

  PDF: 7481

• Atherosclerosis and rheumatoid arthritis: relationships between intima-media thickness of the common carotid arteries and disease activity and disabilty

  G. Cuomo, P. Di Micco, A. Niglio, G. La Montagna, G. Valentini

  242-246

  Published:

  1446

  PDF: 1241

• Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with reumatic diseases

  P. Grypiotis, A. Ruffatti, M. Tonello, C. Winzler, C. Radu, S. Zampieri, M. Favaro, A. Calligaro, S. Todesco

  232-237

  Published:

  1517

  PDF: 5879

• Soluble P-selectin levels in synovial fluid and serum from patients with psoriatic arthritis

  R. Scrivo, A. Spadaro, V. Riccieri, M. Bombardieri, M. Di Franco, D. Celestino, G. Valesini

  250-255

  Published:

  959

  PDF: 649

• Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

  P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

  290-295

  Published:

  1987

  PDF: 1035

• Therapeutic gene transfer for rheumatoid arthritis

  M.C. Boissier, N. Bessis

  51-61

  Published:

  654

  PDF: 669

• TNF-α gene polymorphisms in rheumatoid arthritis patients treated with anti-TNF-α agents: preliminary results

  M. Fabris, E. Di Poi, S. Sacco, G. Damante, L. Sinigaglia, G. Ferraccioli

  19-26

  Published:

  1215

  PDF: 721

• Safety of rituximab in rheumatoid arthritis

  M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni

  101-106

  Published:

  1586

  PDF: 960

• Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

  A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco

  121-126

  Published:

  1647

  PDF: 1654

• Reconstructing the pyramid as a therapeutic approach to rheumatoid arthritis

  G. Ferraccioli

  46-50

  Published:

  653

  PDF: 635

• Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

  M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

  41-49

  Published:

  1126

  PDF: 757

• Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature

  R. Scrivo, F. Conti, F.R. Spinelli, S. Truglia, L. Magrini, M. Di Franco, F. Ceccarelli, G. Valesini

  107-117

  Published:

  1815

  PDF: 1067

• Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity

  E. Bartoloni Bocci, S. Marchesi, F. Delle Monache, G. Vaudo, A. Giordano, F. Ragni Alunni, C. Angrisani, E. Mannarino, Y. Shoenfeld, R. Gerli

  16-21

  Published:

  902

  PDF: 822
• 

  Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs

  L. Degli Esposti, V. Perrone, D. Sangiorgi, L. Sinigaglia

  5-14

  19-04-2021

  Published: 19 April 2021

  3476

  PDF: 487
• 

  Treatment patterns of snti-TNF agents in Italy: an observational study

  L. Punzi, M. Matucci Cerinic, F. Cantini, G. Bagnato, U. Fiocco, C. Ferri, S. Bombardieri

  18-28

  Published:

  1239

  PDF: 914

• Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

  A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

  233-238

  Published:

  981

  PDF: 955

• Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis

  M. Gutierrez, E. Filippucci, L. Bugatti, C. Bertolazzi, W. Grassi

  65-68

  Published:

  1284

  PDF: 951

• Disability and quality of life of patients with rheumatoid arthritis: assessment and perspectives

  F. Salaffi, A. Stancati

  87-106

  Published:

  1191

  PDF: 3301

• short history of anti-rheumatic therapy. IV. Corticosteroids

  G. Pasero, P. Marson

  292-299

  Published:

  1673

  PDF: 1744
• 

  Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)

  G. Carlino, M. Fornaro, L. Santo, R. Bucci, A. Semeraro, L. Quarta, F. D'Onofrio, A. Marsico, C. Zuccaro, P.C. Falappone, D. Mazzotta, F.P. Cantatore, M. Muratore, F. Iannone

  24-30

  01-04-2019

  Published: 1 April 2019

  1356

  PDF: 1012

• Leishmaniasis in rheumatoid arthritis

  C. Pizzorni, M.E. Secchi, M. Cutolo

  235-239

  Published:

  1421

  PDF: 904

• The rehabilitative approach in rheumatoid arthritis

  G. Arioli, S. Maddali Bongi, N. Pappone

  242-248

  Published:

  1636

  PDF: 1906

• Correlation between radiographic, echographic and MRI changes and rheumatoid arthritis progression

  M.A. Cimmino, M. Parodi, E. Silvestri, G. Garlaschi

  28-40

  Published:

  926

  PDF: 2904

• Rheumatoid arthritis: frequency of hospitalization and evaluation of economic burden

  A. Ciocci, L. Buratti, G. Coari, M. Di Franco, A.M. Iagnocco, M.T. Mauceri, A. Serio

  215-222

  Published:

  1036

  PDF: 713
• 

  Association between red cell distribution width and response to methotrexate in rheumatoid arthritis

  M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi

  16-20

  10-04-2020

  Published: 10 April 2020

  1244

  PDF: 662

• Prevalence of rheumatoid arthritis in North Sardinia: the Tempio Pausania’s study

  D. Marotto, M.E. Nieddu, A. Cossu, A. Carcassi

  273-276

  Published:

  738

  PDF: 2151

• Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations

  D. Biscontini, E. Bartoloni Bocci, R. Gerli

  48-53

  Published:

  1336

  PDF: 928